A-317920

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C25H31N3O5
Molecular Weight	453.5307
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

C[C@@H](NC(=O)C1=CC=CO1)C(=O)N2CCN(CCCOC3=CC=C(C=C3)C(=O)C4CC4)CC2

InChI

InChIKey=RTRADBQSZJIRMT-GOSISDBHSA-N

InChI=1S/C25H31N3O5/c1-18(26-24(30)22-4-2-16-33-22)25(31)28-14-12-27(13-15-28)11-3-17-32-21-9-7-20(8-10-21)23(29)19-5-6-19/h2,4,7-10,16,18-19H,3,5-6,11-15,17H2,1H3,(H,26,30)/t18-/m1/s1

HIDE SMILES / InChI

Approval Year

PubMed

Title	Date	PubMed
Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist.	2004-09-01	15294456
Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects.	2003-06	12606603

Name

Type

Language

2-FURANCARBOXAMIDE, N-((1R)-2-(4-(3-(4-(CYCLOPROPYLCARBONYL)PHENOXY)PROPYL)-1-PIPERAZINYL)-1-METHYL-2-OXOETHYL)-

Preferred Name

English

A-317920

Common Name

English

Code System Code Type Description

CAS

360551-59-3

Created by admin on Mon Mar 31 21:48:11 GMT 2025 , Edited by admin on Mon Mar 31 21:48:11 GMT 2025

PRIMARY

PUBCHEM

10389213

Created by admin on Mon Mar 31 21:48:11 GMT 2025 , Edited by admin on Mon Mar 31 21:48:11 GMT 2025

PRIMARY

EPA CompTox

DTXSID00189622

Created by admin on Mon Mar 31 21:48:11 GMT 2025 , Edited by admin on Mon Mar 31 21:48:11 GMT 2025

PRIMARY

FDA UNII

5P909HKP24

Created by admin on Mon Mar 31 21:48:11 GMT 2025 , Edited by admin on Mon Mar 31 21:48:11 GMT 2025

PRIMARY

ACTIVE MOIETY


					5P909HKP24

A-317920